A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression

1. Dominguez-Mozo, M.I.
2. Galán, V.
3. Ramió-Torrentà, L.
4. Quiroga, A.
5. Quintana, E.
6. Villar, L.M.
7. Costa-Frossard, L.
8. Fernández-Velasco, J.I.
9. Villarrubia, N.
10. Garcia-Martinez, M.A.
11. Arroyo, R.
12. Alvarez-Lafuente, R.